Product Information

LACOSAMIDE 200 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.2466 per EA under NDC 50228019560. Its NADAC has been published 160 times since Aug 2, 2023.

FDA first approved this application on Mar 17, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LACOSAMIDE 200 MG TABLET

LACOSAMIDE
$0.2466per EA
DEA Schedule CV

Strength

200 mg/1

NDC

50228019560

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LACOSAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205237

FDA Approved

3/17/2022

TE Code

AB

On Market Since

3/18/2022

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LACOSAMIDE 200 MG TABLET has been published 160 times since Aug 2, 2023, and over the history we have for it it has declined 47.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2466 per EA
All-time high$0.4673 (Aug 16, 2023)
All-time low$0.2466 (Aug 19, 2026)
52-week high$0.3088
52-week low$0.2466
Median price$0.3071
Average price$0.3356
Largest weekly change+31.5% (Aug 21, 2024)
Weeks tracked160
Tracking sinceAug 2, 2023

Price History

1W

-4.5%

1M

-4.5%

3M

-13.1%

6M

-14.8%

1Y

-20.1%

3Y

-47.2%

5Y

N/A

All

-47.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LACOSAMIDE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 200 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.2466 per EA (NDC 50228019560), effective Aug 19, 2026.

How has the price of LACOSAMIDE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for LACOSAMIDE 200 MG TABLET has declined 47.2%. It has been tracked across 160 weekly CMS publications since Aug 2, 2023.

What are the highest and lowest recorded NADAC prices for LACOSAMIDE 200 MG TABLET?

Since Aug 2, 2023, the NADAC for LACOSAMIDE 200 MG TABLET has ranged from a low of $0.2466 (Aug 19, 2026) to a high of $0.4673 (Aug 16, 2023), with a median of $0.3071 per EA.

Are there cheaper alternatives to LACOSAMIDE 200 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LACOSAMIDE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LACOSAMIDE 200 MG TABLET?

LACOSAMIDE 200 MG TABLET (NDC 50228019560) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.